ReviewFrontiers in aging neuroscience2020

Nicotinamide, a Poly [ADP-Ribose] Polymerase 1 (PARP-1) Inhibitor, as an Adjunctive Therapy for the Treatment of Alzheimer's Disease.

Felipe Salech et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.